Sarcosine treatment for oppositional defiant disorder symptoms of attention deficit hyperactivity disorder children.

about

Sarcosine treatment for oppositional defiant disorder symptoms of attention deficit hyperactivity disorder children.

Item

http://www.wikidata.org/entity/Q38839164

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Sarcosine treatment for opposi ...... peractivity disorder children.

@en

type

Item

label

Sarcosine treatment for opposi ...... peractivity disorder children.

@en

prefLabel

Sarcosine treatment for opposi ...... peractivity disorder children.

@en

P1476

Sarcosine treatment for opposi ...... peractivity disorder children.

@en

P2093

Guochuan E Tsai

http://www.w3.org/2001/XMLSchema#string

Hsien-Yuan Lane

http://www.w3.org/2001/XMLSchema#string

Ruu-Fen Tzang

http://www.w3.org/2001/XMLSchema#string

Yue-Cune Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Dances with black widow spiders: Dysregulation of glutamate signalling enters centre stage in ADHD

Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis

Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia

Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences

Acute D-serine treatment produces antidepressant-like effects in rodents

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.

P304

976-982

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0269881116658986

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27443598

http://www.w3.org/2001/XMLSchema#string